Adicet Bio (1IJ) Financial Statements
Adicet Bio Financial Overview
Adicet Bio's market cap is currently $28.67M. The company's EPS TTM is $-11.45; its P/E ratio is -0.30; Adicet Bio is estimated to report earnings on November 11, 2026, and the estimated EPS forecast is $-1.41. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 24.99M | $ 9.73M |
| Gross Profit | $ -6.38M | $ 0.00 | $ 0.00 | $ 24.99M | $ 9.73M |
| Operating Income | $ -122.11M | $ -127.61M | $ -152.04M | $ -72.55M | $ -61.43M |
| EBITDA | $ -110.39M | $ -110.65M | $ -136.53M | $ -67.04M | $ -60.41M |
| Net Income | $ -116.80M | $ -117.12M | $ -142.66M | $ -69.79M | $ -62.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 158.53M | $ 176.30M | $ 159.71M | $ 257.66M | $ 277.54M |
| Total Assets | $ 192.35M | $ 220.22M | $ 207.29M | $ 330.69M | $ 338.94M |
| Total Debt | $ 14.74M | $ 17.23M | $ 20.92M | $ 21.02M | $ 20.94M |
| Net Debt | $ -24.18M | $ -39.26M | $ -138.79M | $ -236.63M | $ -256.60M |
| Total Liabilities | $ 33.15M | $ 33.61M | $ 37.12M | $ 38.35M | $ 35.81M |
| Stockholders' Equity | $ 159.21M | $ 186.61M | $ 170.18M | $ 292.34M | $ 303.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -96.98M | $ -93.50M | $ -98.18M | $ -61.55M | $ -64.10M |
| Operating Cash Flow | $ -95.25M | $ -92.38M | $ -93.72M | $ -44.77M | $ -51.05M |
| Investing Cash Flow | $ 2.39M | $ -119.24M | $ -4.46M | $ -16.78M | $ -2.80M |
| Financing Cash Flow | $ 75.25M | $ 111.31M | $ 236.00K | $ 41.51M | $ 242.69M |
Currency in USD
